sábado, 26 de junio de 2021

Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety | BMC Cancer | Full Text

Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety | BMC Cancer | Full Text

No hay comentarios:

Publicar un comentario